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Age of Sexual Initiation, Psychiatric Symptoms, and Sexual Risk
Behavior among Ecstasy and LSD Users in Porto Alegre, Brazil:
A Preliminary Analysis
Flavio Pechansky, Lysa Remy, Hilary L. Surratt, Steven P. Kurtz, Thiago Botter Maio
Rocha, Lisia Von Diemen, Daniela Benzano Bumaguin, and James Inciardi
Abstract
Ecstasy and LSD use is widespread in large Brazilian cities, but there is limited information on
their use among young, middle-class, club goers in Brazil. We conducted standardized face-to-
face interviews with 200 male and female ecstasy and/or LSD users, focusing on drug use and
sexual history, current risk behaviors, and psychiatric symptomatology. Participants with early
sexual debut (before 14) were more likely to report lifetime use of marijuana and powder and
crack cocaine than those with later sexual initiation. Early sexual debut was associated with past
year sexual risk behaviors, including having sex while high (Prevalence Ratio (PR)=1.3), having
two or more sex partners (PR=1.3), as well as history of sexual abuse (PR=13.6). Depression and
anxiety scores were similar by age of sexual initiation. The implications of these findings are
discussed.
Introduction
Recent international reports suggest a trend of stabilization in ecstasy—
(methylenedioxymethamphetamine, or MDMA)—(Volkow, 2006) and lysergic acid
diethylamide (LSD) (Leshner, 2001) use in many parts of the world, with European data
indicating an actual decline in annual prevalence rates. Nevertheless, ecstasy and LSD use
continues to grow in some areas, with recent data documenting increased prevalence of use
in Central and South America (United Nations Office on Drugs and Crime [UNODC],
2008). Recent reports from Brazil reflect an increase in the prevalence of ecstasy use, as
well as increases in seizures, trafficking and manufacturing of ecstasy (UNODC, 2008).
Large cities in Brazil now report widespread ecstasy and LSD use compared to previous
studies (Andrade, Duarte, & de Oliveira, 2010; Galduróz, Noto, Nappo, & Carlini, 2005),
occurring typically among urban, young, middle- and upper-class club goers (Battisti, Noto,
Nappo, & Carlini, 2006; De Almeida & Silva, 2005; De Micheli & Formigoni, 2004;
Soldera, Dalgalarrondo, Corrêa Filho, & Silva, 2004), a pattern that has been seen in other
countries as well (Fendrich, Wislar, Johnson, & Hubbell, 2003; Parks & Kennedy, 2004;
Ramo, Grov, Delucchi, Kelly, & Parsons, 2010). At the same time, little is known about the
characteristics of club drug users in Brazil, particularly with regard to the association of
ecstasy and LSD and their effects on sexual behaviors and psychiatric symptomatology.
Previous work done elsewhere has demonstrated an association between ecstasy use and
risky sexual behavior (Klitzman, Greenberg, Pollack, & Dolezal, 2002) and increased
psychiatric symptomatology (Breen et al., 2006; Keyes, Martins, & Hasin, 2008; Montoya,
Sorrentino, Lukas, & Price, 2002) as well. Nevertheless, these phenomena have yet to be
investigated in the Brazilian context.
Early sexual initiation has been associated with a series of adverse health consequences in
later life, including risky sexual behavior, unintended pregnancy, abortion, sexually
transmitted infections (Ma et al., 2009), early drug initiation, and higher risk of tobacco,
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alcohol, and cannabis use, as well as higher rates of drug abuse and dependence. Recent
ecstasy use has been associated with early sexual initiation, concurrent use of other drugs
and current risky sexual behaviors (Brook, Brook, Zhang, Cohen, & Whiteman, 2002; Coker
et al., 1994; McGue & Iacono, 2005; Poikolainen et al., 2001; Stanton, Li, Cottrell, &
Kaljee, 2001; Staton et al., 1999). Regarding LSD use, however, little is known in this
regard. A number of social and legal problems associated with early sexual initiation have
also been documented, including a greater likelihood of involvement in drug dealing,
carrying weapons and violence (Coker, et al., 1994). Although some studies did not show
this type of relationship (Li et al., 2001), the bulk of scientific findings on this topic
characterizes early sexual initiation as a major risk factor for later problem behavior in the
aforementioned areas.
Sexual abuse is clearly identified—as is early sexual initiation—as a major risk factor for
psychiatric illness, and wide-ranging studies have also linked sexual abuse to numerous
drug-related consequences, such as early alcohol use, regular tobacco use, illicit drug use,
abuse and dependence, and early injection drug use, along with higher rates of prescription
drug abuse (Bensley, Spieker, Van Eenwyk, & Schoder, 1999; Duncan et al., 2008;
Harrison, Hoffmann, & Edwall, 1989; Hayatbakhsh, Najman, Bor, O’Callaghan, &
Williams, 2009; Nelson et al., 2006; Ompad et al., 2005; Sartor et al., 2007). With regard to
drug initiation, recent ecstasy use has been related to a history of early sexual initiation,
concurrent use of other drugs and current risky sexual behavior (Novoa, Ompad, Wu,
Vlahov, & Galea, 2005). Little is known about LSD use and its relation with early sexual
debut or associated behaviors.
In Brazil, ecstasy and other club drug use is an emerging phenomenon. Although ecstasy
was first introduced in Brazil as early as 1994, by most accounts its use remained localized
and sporadic until recent years. The few published studies on this topic in Brazil suggest that
ecstasy users are often polydrug abusers—using more than one drug at the same time—and
have significantly higher rates of illicit and prescription drug abuse than do non-ecstasy
users (De Almeida & Silva, 2003; De Almeida & Silva, 2005). We sought to understand the
emerging club drug epidemic in the South of Brazil, and to investigate the extent to which
Brazilian club drug users are at high risk for both physical and mental health consequences.
In particular, this paper examines the connections of club drug use, risky sexual behavior,
early sexual initiation, and psychological functioning in a sample of urban, young, LSD and/
or ecstasy users in Porto Alegre, a large metropolitan capital city in the South of Brazil.
Method
Study eligibility criteria included being age 18 to 39; and having used ecstasy and/or LSD at
least once in the 90 days prior to interview. Exclusion criteria included currently
participating in treatment for drug or alcohol problems. Recruitment was conducted from
March through July of 2010, using a venue based sampling approach. Project staff, in
conjunction with “key informants” in the club scene, mapped the primary club “hot spots”
(bars featuring electronic music, nightclubs, rave parties, and parks), where potential
participants were known to congregate. Potential participants were approached by project
staff in these locations on Thursday, Friday, and Saturday evenings or late nights, as well as
on Sunday afternoons in local parks where groups of participants would get together).
Typically, the “club scene” in Porto Alegre is concentrated in highly localized areas of
specific neighborhoods, ranging from upscale areas with sophisticated night clubs in which
well-known DJs perform, to simpler clubs that attract lower income club goers. Club goers
in Porto Alegre tend to be limited in the numbers of clubs they frequent, having established
relatively insular groups in a select few venues. Many also form online chat communities (to
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learn about upcoming music events, as well as to discuss what occurred while “chilling out”
(recovering from the “balada”—a long night out with music and drugs). Some of these chat
members include DJs or others involved in the production of electronic music activities, and
they use these groups to publicize the “electronic culture.”
Much of the drug-related activity and partying happens not only inside club venues, but also
on the queuing lines that form at the entrance. Many patrons spend substantial time outside
the clubs, engaging in alcohol and drug use, and meeting friends and acquaintances. The
queues served as good contact points for field staff to approach potential participants, since
it would not be possible to collect data inside the clubs due to the noise and atmosphere. On
the specific dates for data collection, the interviewers would cover predetermined contact
sites in pairs or small groups, and interviews were obtained in loco. Field interviewers were
trained to collect data with particular emphasis on elements of rapport, street terminology of
drug use, and confidentiality and privacy of the information obtained. All interview data was
recorded using brief, paper and pencil questionnaires (see below). At the end of the
interview, which would last on average 15 minutes, participants received a lunch voucher as
a compensation for their participation. The project was approved by both The University of
Delaware Institutional Review Board and the Hospital de Clinicas Ethics Committee and
Office of Human Subjects Protection at the Federal University of Rio Grande do Sul.
Instrumentation
In order to identify eligible participants, we developed a brief screening form, based on
forms developed in the U.S. for similar populations (Ibañez, Kurtz, Surratt, & Inciardi,
2010; Inciardi, Surratt, Kurtz, & Cicero, 2007). A shortened version of the GAIN (Global
Appraisal of Individual Needs) interview was utilized as the primary data collection
instrument (Dennis, Titus, White, Unsicker, & Hodgkins, 2002). This instrument comprises
eight sections to ascertain specific information on (1) demographics, (2) substance use, (3)
physical health, (4) risk behaviors, (5) mental health, (6) environment, (7) legal, and (8)
vocational. Each of the sections contains questions on the recency of problems and the
intensity of symptoms. Interview items are combined in scales and subscales, and these can
be used for DSM-IV diagnoses. The GAIN has been used both in adolescents and adults, in
a variety of settings, and is the main clinical and research measure for many NIDA-funded
multicentric studies, with strong psychometric properties (Chan, Passetti, Garner, Lloyd, &
Dennis, 2010). Cronbach alphas for all scales and subscales were over .7 (more detail on
scale development can be found at http://www.chestnut.org/LI/gain/index.html).
The adaptations were focused on shortening the instrument, since it was to be used for brief
intercept interviewing in street locations. The following sections were kept in the final
format: (1) substance use, (2) mental health, (3) risk behaviors, and (4) vocational, but were
shortened and adapted for the Brazilian context. Questions related to basic demographics
assessed age, gender, education in terms of years of schooling, and monthly individual
income.
Sexual behavior questions were dichotomous, and covered the period of 12 months prior to
the interview. Participants were also asked to report frequency of vaginal, oral, and anal sex
activity and condom use in the 90 days prior to interview.
Substance use was assessed by asking participants how many times a particular substance
was used in the 90 days prior to interview and lifetime. Substances included a
comprehensive list of both illicit drugs and prescription-type drugs.
As for psychiatric symptoms, these were assessed using the mental health section of the
GAIN with focus on anxiety and depression. Depressive symptoms were assessed by 9 items
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(“During the past 12 months, have you had significant problems with feeling very trapped,
lonely, sad, blue, depressed, or hopeless about the future?”). Anxiety symptoms were
assessed by 12 items, such as: “During the past 12 months, have you had significant
problems feeling very anxious, nervous, tense, scared, panicked or like something bad was
going to happen?” All scale items used a dichotomous response format (yes/no). Total
scores on each of the subscales were additive.
Analytic plan
Data analyses were conducted using SPSS/PASW (Statistical Package for the Social
Sciences) v.18. Frequencies and percentages were obtained for all variables of interest.
Condom use and drug use variables were recoded as dichotomous (yes/no) variables for
analysis.
Our primary goal in this analysis was to examine patterns of sexual risk among this sample
of club drug users, including early sexual debut and its association with other types of drug
use, sexual behaviors and general demographic factors. We defined early sexual initiation as
any type of sexual relation before the age of 14.
Dichotomous variables were compared using the Chi-Square test with Yates correction.
Continuous variables were compared using Student’s t test for independent samples. We
describe the Prevalence Ratios (PR) for the different outcomes and their respective
confidence intervals (CI). PR was adjusted for potential confounders using Poisson
Regression with robust variance.
Results
Subjects in the study were predominantly male—around 70%, and most had at least 11 years
of schooling. The majority were either employed or were students, and the most frequent
monthly individual income was the equivalent of approximately US$ 600, which is about
three times the monthly minimum wage in Brazil. We found no statistical differences
(P<0.05) in demographic characteristics with regard to age of sexual debut and these are
described in Table 1. The mean age of the sample was 22.8 (SD = 4.5). As for race, all study
participants were white (Caucasian).
With regard to overall drug use, the most frequently reported use—both lifetime and for the
90 days prior to interview—were alcohol, marijuana, ecstasy and LSD, as can be seen in
Figure 1. The average lifetime number of drugs used by the participants was 5.5 (SD=1.7),
with no gender differences (P=0.198). The average number of different drugs used for the
90 days prior to interview was 3.8 (SD=1.3), with no difference between genders (P=0.847).
The typical sequence reported for drug use onset mentioned for at least half of the sample
was as follows: alcohol= 13,5 (SD=2), marijuana=15.5 (SD=2.7), inhalants=16.5 (SD=3.7),
crack=17.1 (SD=2), cocaine=17.8 (SD=3),, ecstasy=19.5 (SD=3.9) and finally LSD=19.6
(SD=3.7). The median of days of drug use among those with early sexual debut was 86
(Interquartile range: 39 to 134), and the median of days of drug among the late debut group
was 52 (Interquartile range: 34 to 88) (P<0.001).
Overall, the mean age reported for first sexual relation (either vaginal, oral, or anal) was
14.7 (SD=2.2), with no difference between genders (P=0.190). With regard to sexual
behavior during the previous 12 months, 78.5% of the sample reported having had sex under
the influence of alcohol or drugs, 66.5% engaged in unprotected sex, 62.5% reported sex
with two or more partners, and 41% reported anal sex. Anal sex differed by gender: 47.5%
among women and 26.2% among men (P=0.008). Significant differences by gender were
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also observed for using drugs, gifts, or money to obtain sex (men 16.5%, vs. women 1.6%,
P=0.006), and having two or more sex partners (men 67.6%, vs. women 50.8%, P=0.036).
Twenty-five (30.1%) of those reporting sex before the age of 14 reported current same-sex
relations, vs. 30 (25.6%) who had their first sexual encounter after 14, with no significant
difference (P=0.590). (RP: 1,2 CI 95%: 0.7–1.8).
Although we found no significant differences in demographic variables and early/later
sexual debut, we observed a trend for gender and education and these were included as
controls in the multivariate analyses displayed in Table 2. We found a significant association
for the variables had sex while high on alcohol or drugs, had multiple sexual partners (last
12 months), and sex trading, adjusted for gender and education.
Overall, participants reported 0–1 (none or minor) depression symptoms in 30.5% of the
cases, 2–5 (moderate) symptoms in 50%, and 6–9 (severe) symptoms in 19.5% of cases. For
anxiety symptoms, these were reported as none or minor (0–1) in 34% of the cases,
moderate (2–6) in 55.5%, and severe (7–12) in 10.5% of cases. We found no significant
association with age of sexual debut, even when adjusting for potential confounders such as
gender and education. None or minor depressive symptoms were reported in 23 (27.7%) of
the participants who had sex before 14 and 38 (32.5%) for the other group, and moderate/
severe symptoms were reported by 60 (72.3%) and 79 (67.5%), respectively (P=0.57). None
or minor anxiety symptoms were reported by 23 (27.7%) of early sexual debut participants
and 45 (38.5%) of later sexual debut participants, and moderate/severe by 60 (72.3%) and
72(61.5%), respectively (P=0.15).
Table 3 shows that participants who reported early sexual debut reported higher lifetime
prevalence of all types of substance use; however, when adjusted for gender and education,
significant associations were found for marijuana, inhalant use and cocaine and crack use.
Discussion
Recent surveillance data have indicated that the use of club drugs is a widespread and
growing problem in Brazil, and this study provides some of the first systematic data on
ecstasy and LSD use among young, urban, middle class club goers in Porto Alegre, Brazil.
Overall, drug use was frequent in this sample, particularly for alcohol and marijuana. This is
similar to earlier findings that documented early initiation and nearly universal use of
alcohol and marijuana among club goers in Miami (Kurtz, Inciardi, Surratt, & Cottler,
2005). Drugs associated with the “club scene,” in this case ecstasy and LSD, were reported
at much later ages of onset (around 19). This may have to do with having the resources to
purchase these drugs, which are typically more expensive in the Brazilian market compared
to alcohol and marijuana. Also, access is an important issue. The legal age of entry to clubs
in Porto Alegre is 18 and enforcement is stringent, which may explain the later onset. This
finding is consistent with others obtained from similar samples in the literature (Lomba et
al., 2008).
The issue of sexual initiation and sexual risk is important to discuss given the characteristics
of the sample we described. Participants who reported early sexual debut had higher
prevalence of all categories of substance use compared to those with later sexual debut,
especially for cocaine and crack. We hypothesize that early sexual initiation is a risk factor
for later cocaine/crack use in our sample, and particularly for women with histories of sexual
coercion, which is supported by existing literature (Hyman et al., 2008; Young & Boyd,
2000).
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Participants reporting early sexual debut were more likely to report drug use associated with
sexual activity, which is found in existing literature with regard to early initiation of sex
(Bellis et al., 2008; Stanton, Li, Cottrell, & Kaljee et al., 2001; Wang, Storr, Browne, &
Wagner, 2010). In a study developed in eight African countries with adolescents (Peltzer,
2010), for example, the authors reported a high prevalence of early sexual debut. Early
sexual debut was correlated with substance use, number of sexual partners, and increased
risk of HIV acquisition and transmission, as well as high rates of unprotected sex. As the
authors discuss, these risk factors are consistent with Jessor and Jessor’s theory of problem
behavior (Jessor & Jessor, 1977), which suggests that early sexual relations can be seen as a
marker for future development of potentially risky behaviors such as drug use or unprotected
sex, or both. This would appear to be a plausible explanation for the patterns of risk
behavior in the current sample.
Other aspects of elevated sexual risk were also present in those with early sexual onset.
Drugs, gifts or money in exchange for sex was more likely to be reported among early
sexual debut respondents, when compared to late sexual initiators. Those with early debut
also reported more sexual partners in lifetime, and were more likely to report use of alcohol
or drugs to make sex last longer or hurt less. These would appear to be clustered indicators
of risk. As has been well described in literature, prolonged sex under the effects of drugs
may facilitate the dissemination of HIV (Colfax & Guzman, 2006; Ibañez, et al., 2010) and
other sexually-transmitted infections. These data suggest a combination of risks that needs to
be studied in further detail in these young, sexually active polydrug users.
An additional finding that requires further investigation is the high prevalence of anal sex
encounters among male and female genders. Prevalences found here are much higher than
the general population and than other drug-using populations. As reported by Ibañez and
colleagues. (2010), there may be a cultural influence on these findings, since in their study
with urban club goers of Miami, heterosexual anal sex was more commonly found among
Latinos than African-American respondents. Of interest in the current study, there was also a
trend toward higher anal sex prevalence among those with early sexual debut relative to later
initiators. This may be an additional indicator of higher sexual risk taking related to early
experience.
We found no differences with regard to psychiatric manifestations of anxiety and depression
according to age of sexual initiation, although a significant portion of our sample reported
severe anxiety and depression symptoms, in a much higher rate than the overall population
(Lima, 1999). This is consistent with current literature on the topic, which has provided
conflicting evidence for the association between early sexual debut and depressive
symptomatology (Needham, 2007; Sabia, 2006) and anxiety (Ramrakha et al., 2007). A
recent report suggests that depression and early sexual debut could be concomitant outcomes
of biopsychosocial processes and not be linked in a direct causal relationship (Jamieson &
Wade, 2010). It may be that the heavy poly-drug use of our sample and high prevalence of
psychological problems limits our ability to discern an association with sexual debut. This
may be an area of interest for future research.
This is the first and preliminary analysis of data obtained from a sample of active club drug
users in Porto Alegre, Brazil. Because of its cross-sectional design, this paper is necessarily
exploratory, aimed at a preliminary description of the substance use, sexual, and
psychological characteristics of our sample. Age of sexual initiation appeared to divide our
sample of club users into two different groups, particularly with regard to risky sexual
behaviors. Although some of these associations did not reach statistical significance, small
sample sizes may have lead to insufficient power. Also, the associations found cannot be
deemed causal due to the study design.
Pechansky et al. Page 6
J Drug Issues. Author manuscript; available in PMC 2012 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Acknowledgments
The authors thank data collectors Sinara Santos, Fernanda Cubas de Paula, Graciela Pasa, Gabriela Moraes, Camila
Bitencourt, Bruno Rech, Madson Gomes, and Rodrigo Sibemberg for their efforts in the data collection process.
This study was supported by Fogarty International Center Grant 1R03TW007612-01A1 and Fundo de Incentivo e
Auxílio à Pesquisa (FIPE) from the Hospital de Clinicas of Porto Alegre, Brazil (GPPG-HCPA – n°07-391)
References
Andrade, AG.; Duarte, PC.; de Oliveira, LG. I Levantamento Nacional sobre o uso de álcool, tabaco e
outras drogas entre universitários das 27 capitais brasileiras. 2010. Retrieved from
http://www.grea.org.br/I_levantamento/I_levantamento_nacional.pdf
Battisti M, Noto A, Nappo S, Carlini EA. A profile of Ecstasy (MDMA) use in São Paulo, Brazil: An
ethnographic study. Journal of Psychoactive Drugs. 2006; 38(1):13–18. [PubMed: 16681171]
Bellis M, Hughes K, Calafat A, Juan M, Ramon A, Rodriguez J, Mendes F, Schnitzer S, Phillips-
Howard P. Sexual uses of alcohol and drugs and the associated health risks: a cross sectional study
of young people in nine European cities. BioMed Central Public Health. 2008; 8:155. [PubMed:
18471281]
Bensley L, Spieker S, Van Eenwyk J, Schoder J. Self-reported abuse history and adolescent problem
behaviors. II. Alcohol and drug use. Journal of Adolescent Health. 1999; 24(3):173–180. [PubMed:
10195800]
Breen C, Degenhardt L, Kinner S, Bruno R, Jenkinson R, Matthews A, Newman J. Alcohol use and
risk taking among regular ecstasy users. Substance Use & Misuse. 2006; 41(8):1095–1109.
[PubMed: 16798678]
Brook D, Brook J, Zhang C, Cohen P, Whiteman M. Drug use and the risk of major depressive
disorder, alcohol dependence, and substance use disorders. Archives of General Psychiatry. 2002;
59(11):1039–1044. [PubMed: 12418937]
Chan Y, Passetti L, Garner B, Lloyd J, Dennis M. HIV risk behaviors: Risky sexual activities and
needle use among adolescents in substance abuse treatment. AIDS Behavior. 2011; 15(1):114–124.
Coker A, Richter D, Valois R, McKeown R, Garrison C, Vincent M. Correlates and consequences of
early initiation of sexual intercourse. Journal of School Health. 1994; 64(9):372–377. [PubMed:
7877279]
Colfax G, Guzman R. Club drugs and HIV infection: a review. Clinical Infectious Diseases. 2006;
42(10):1463–1469. [PubMed: 16619161]
de Almeida S, Silva M. Ecstasy (MDMA): Effects and patterns of use reported by users in São Paulo.
Revista Brasileira de Psiquiatrja. 2003; 25(1):11–17.
De Almeida S, Silva M. Characteristics of ecstasy users in Sãio Paulo, Brazil. Substance Use &
Misuse. 2005; 40(3):395–404. [PubMed: 15776985]
De Micheli D, Formigoni M. Drug use by Brazilian students: Associations with family, psychosocial,
health, demographic and behavioral characteristics. Addiction. 2004; 99(5):570–578. [PubMed:
15078231]
Dennis, ML.; Titus, JC.; White, MK.; Unsicker, JI.; Hodgkins, D. Global Appraisal of Individual
Needs—Initial (GAIN-I). 2002. Retrieved from http://www.chestnut.org/LFgain/Gadm1299.pdf
Duncan A, Sartor C, Scherrer J, Grant J, Heath A, Nelson E, Jacob T, Bucholz KK. The association
between cannabis abuse and dependence and childhood physical and sexual abuse: evidence from
an offspring of twins design. Addiction. 2008; 103(6):990–997. [PubMed: 18482422]
Fendrich M, Wislar J, Johnson T, Hubbell A. A contextual profile of club drug use among adults in
Chicago. Addiction. 2003; 98(12):1693–1703. [PubMed: 14651501]
Galduróz J, Noto A, Nappo S, Carlini E. Household survey on drug abuse in Brazil: Study involving
the 107 major cities of the country—2001. Addictive Behaviors. 2005; 30(3):545–556. [PubMed:
15718070]
Harrison P, Hoffmann N, Edwall G. Differential drug use patterns among sexually abused adolescent
girls in treatment for chemical dependency. International Journal of the Addictions. 1989; 24(6):
499–514. [PubMed: 2599679]
Pechansky et al. Page 7
J Drug Issues. Author manuscript; available in PMC 2012 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Hayatbakhsh M, Najman J, Bor W, O’Callaghan M, Williams G. Multiple risk factor model predicting
cannabis use and use disorders: A longitudinal study. American Journal of Drug and Alcohol
Dependence. 2009; 35(6):399–407.
Hyman S, Paliwal P, Chaplin T, Mazure C, Rounsaville B, Sinha R. Severity of childhood trauma is
predictive of cocaine relapse outcomes in women but not men. Drug Alcohol Dependence. 2008;
92(1–3):208–216.
Ibañez G, Kurtz S, Surratt H, Inciardi J. Correlates of heterosexual anal intercourse among substance-
using club-goers. Archives of Sexual Behavior. 2010; 39(4):959–967. [PubMed: 20217224]
Inciardi J, Surratt H, Kurtz S, Cicero T. Mechanisms of prescription drug diversion among drug-
involved club-and street-based populations. Pain Medicine. 2007; 8(2):171–183. [PubMed:
17305688]
Jamieson L, Wade T. Early age of first sexual intercourse and depressive symptomatology among
adolescents. Journal of Sexual Research. 2010:1–11.
Jessor, R.; Jessor, SL. Problem behavior and psychosocial development: A longitudinal study of youth.
New York: Academic Press; 1977.
Keyes K, Martins S, Hasin D. Past 12-month and lifetime comorbidity and poly-drug use of ecstasy
users among young adults in the United States: Results from the National Epidemiologic Survey
on Alcohol and Related Conditions. Drug & Alcohol Dependence. 2008; 97(1–2):139–149.
[PubMed: 18524499]
Klitzman R, Greenberg J, Pollack L, Dolezal C. MDMA (‘ecstasy’) use, and its association with high
risk behaviors, mental health, and other factors among gay/bisexual men in New York City. Drug
& Alcohol Dependence. 2002; 66(2):115–125. [PubMed: 11906799]
Kurtz S, Inciardi J, Surratt H, Cottier L. Prescription drug abuse among ecstasy users in Miami.
Journal of Addictive Diseases. 2005; 24(4):1–16. [PubMed: 16368653]
Leshner, AI. Hallucinogens and Dissociative Drugs. NIDA Research Report Series 2007. 2001.
Retrieved from http://www.drugabuse.gov/PDF/RRHalluc.pdf
Li X, Stanton B, Cottrell L, Burns J, Pack R, Kaljee L. Patterns of initiation of sex and drug-related
activities among urban low-income African-American adolescents. J Adolesc Health. 2001; 28(1):
46–54. [PubMed: 11137906]
Lima MSD. Epidemiologia e impacto social. Revista Brasileira de Psiquiatria. 1999; 21:01–05.
Lomba L, Apostolo J, Loureiro H, Gravet J, Silva M, Mendes F. Consumos e comportamentos sexuais
de risco na noite de Coimbra. Revista Toxicodependencias. 2008; 14(1):10.
Ma Q, Ono-Kihara M, Cong L, Xu G, Pan X, Zamani S, Ravari SM, Zhang D, Homma T, Kihara M.
Early initiation of sexual activity: A risk factor for sexually transmitted diseases, HTV infection,
and unwanted pregnancy among university students in China. BioMed Central Public Health.
2009; 9:111. [PubMed: 19383171]
McGue M, Iacono W. The association of early adolescent problem behavior with adult
psychopathology. American Journal of Psychiatry. 2005; 162(6):1118–1124. [PubMed: 15930060]
Montoya A, Sorrentino R, Lukas S, Price B. Long-term neuropsychiatric consequences of “ecstasy”
(MDMA): A review. Harvard Review of Psychiatry. 2002; 10(4):212–220. [PubMed: 12119307]
Needham B. Gender differences in trajectories of depressive symptomatology and substance use
during the transition from adolescence to young adulthood. Social Science Medicine. 2007; 65(6):
1166–1179. [PubMed: 17574316]
Nelson E, Heath A, Lynskey M, Bucholz K, Madden P, Statham D, Martin NG. Childhood sexual
abuse and risks for licit and illicit drug-related outcomes: A twin study. Psychological Medicine.
2006; 36(10):1473–1483. [PubMed: 16854248]
Novoa R, Ompad D, Wu Y, Vlahov D, Galea S. Ecstasy use and its association with sexual behaviors
among drug users in New York City. Journal of Community Health. 2005; 30(5):331–343.
[PubMed: 16175956]
Ompad D, Ikeda R, Shah N, Fuller C, Bailey S, Morse E, Kerndt P, Maslow C, Wu Y, Vlahov D,
Garfein R, Strathdee SA. Childhood sexual abuse and age at initiation of injection drug use.
American Journal of Public Health. 2005; 95(4):703–709. [PubMed: 15798133]
Parks K, Kennedy C. Club drugs: Reasons for and consequences of use. Journal of Psychoactive
Drugs. 2004; 36(3):295–302. [PubMed: 15559677]
Pechansky et al. Page 8
J Drug Issues. Author manuscript; available in PMC 2012 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Peltzer K. Early sexual debut and associated factors among in-school adolescents in eight African
countries. Acta Paediatrica. 2010; 99(8):1242–1247. [PubMed: 20491706]
Poikolainen K, Tuulio-Henriksson A, Aalto-Setälä T, Marttunen M, Anttila T, Lönnqvist J. Correlates
of initiation to cannabis use: A 5-year follow-up of 15–19-year-old adolescents. Drug & Alcohol
Dependence. 2001; 62(3):175–180. [PubMed: 11295321]
Ramo D, Grov C, Delucchi K, Kelly B, Parsons J. Typology of club drug use among young adults
recruited using time-space sampling. Drug & Alcohol Dependence. 2010; 107(2–3):119–127.
[PubMed: 19939585]
Ramrakha S, Bell M, Paul C, Dickson N, Moffitt T, Caspi A. Childhood behavior problems linked to
sexual risk taking in young adulthood: A birth cohort study. Journal of the Academy of Child and
Adolescent Psychiatry. 2007; 46(10):1272–1279.
Sabia J. Does early adolescent sex cause depressive symptoms? Journal of Policy Analysis and
Management. 2006; 25(4):803–825. [PubMed: 16989034]
Sartor C, Lynskey M, Bucholz K, McCutcheon V, Nelson E, Waldron M, Heath AC. Childhood sexual
abuse and the course of alcohol dependence development: Findings from a female twin sample.
Drug & Alcohol Dependence. 2007; 89(2–3):139–144. [PubMed: 17227698]
Soldera M, Dalgalarrondo P, Corrêa Filho H, Silva C. Use of psychotropics drugs among students:
Prevalence and associated social factors. Revista de Saúde Público. 2004; 38(2):277–283.
Stanton B, Li X, Cottrell L, Kaljee L. Early initiation of sex, drug-related risk behaviors, and
sensation-seeking among urban, low-income African-American adolescents. Journal of the
National Medical Association. 2001; 93(4):129–138. [PubMed: 12653400]
Staton M, Leukefeld C, Logan T, Zimmerman R, Lynam D, Milich R, Martin C, McClanahan K,
Clayton R. Risky sex behavior and substance use among young adults. Health & Social Work.
1999; 24(2):147–154. [PubMed: 10340165]
United Nations Office on Drugs and Crime (UNODC). World drug report. 2008. Retrieved from
http://www.unodc.org/documents/wdr/WDR_2008/WDR_2008_eng_web.pdf
Volkow, ND. MDMA (Ecstasy) Abuse. NIDA Research Report Series 2007. 2006. Retrieved from
http://www.drugabuse.gov/PDF/RRmdma.pdf
Wang Y, Storr C, Browne D, Wagner F. Early sexual experience and later onset of illegal drug use
among African American students on HBCU campuses. Substance Use & Misuse. 2010
Young A, Boyd C. Sexual trauma, substance abuse, and treatment success in a sample of African
American women who smoke crack cocaine. Substance Abuse. 2000; 21(1):9–19. [PubMed:
12466644]
Biographies
Flavio Pechansky, MD, Ph.D., is Associate Professor and Director of the Center for Drug
and Alcohol Research and the Department of Psychiatry of the Federal University of Rio
Grande do Sul, Brazil. He is visiting scientist and has research activities associated with the
Universities of Delaware, Pennsylvania, and Kentucky.
Lysa Remy, BA, MSc, received her graduate and Master’s Degree in Psychology from
Pontificate Catholic University of Rio Grande do Sul (PUCRS)/Brazil. At present, she is a
doctoral student in medicine at the postgraduate program in psychiatry at the Federal
University of Rio Grande do Sul (UFRGS)/Brazil.
Hilary L. Surratt, Ph.D. is a Senior Scientist, Center for Drug and Alcohol Studies,
University of Delaware. She is Principal Investigator of a NIDA-funded epidemiologic
study of antiretroviral medication diversion among HIV+ substance abusers in Miami, and
has published widely in the areas of HIV/AIDS, substance abuse, and drug diversion.
Steven P. Kurtz(Ph.D. in Sociology) is Senior Scientist and Associate Director of the Coral
Gables, Florida office of the Center for Drug and Alcohol Studies at the University of
Pechansky et al. Page 9
J Drug Issues. Author manuscript; available in PMC 2012 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Delaware. He is a NIDA-funded investigator with a research focus on the development of
HIV and substance abuse prevention interventions.
Thiago Botter Maio Rocha, MD, is a senior resident in Psychiatry for the Department of
Psychiatry of the Hospital de Clinicas de Porto Alegre and Federal University of Rio Grande
do Sul and a research assistant of the Center for Drug and Alcohol Research of UFRGS.
Lisia Von Diemen, MD, MSc, is a psychiatrist at Hospital de Clinicas de Porto Alegre and
Associate Researcher at the Center for Drug and Alcohol Research of UFRGS. At present,
she is a Doctoral student in Medicine at the Postgraduate Program in Psychiatry at the
Federal University of Rio Grande do Sul (UFRGS)/Brazil.
Daniela Benano Bumaguin is undergraduate student of statistics of the Federal University
of Rio Grande do Sul, and research assistant at the Center for Drug and Alcohol Research of
UFRGS.
James A. Inciardi, Ph.D., was Professor in the Department of Sociology and Criminal
Justice and Founding Director of the Center for Drug and Alcohol Studies at the University
of Delaware.
Pechansky et al. Page 10
J Drug Issues. Author manuscript; available in PMC 2012 March 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1.
Lifetime and 90-Day Use of Drugs Reported by Subjects (N%)
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